Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy

Front Immunol. 2022 May 18:13:903679. doi: 10.3389/fimmu.2022.903679. eCollection 2022.

Author

Adit Ben-Baruch¹

Affiliation

¹ The Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.

No abstract available

Keywords: TNFR1; TNFR2; cancer; personalized therapy; tumor necrosis factor α/TNFα.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Humans
Neoplasms* / drug therapy
Receptors, Tumor Necrosis Factor, Type I
Receptors, Tumor Necrosis Factor, Type II
Tumor Necrosis Factor-alpha*

Substances

Receptors, Tumor Necrosis Factor, Type I
Receptors, Tumor Necrosis Factor, Type II
Tumor Necrosis Factor-alpha